Schneeweiss, A. (2015). Pertuzumab: Effektive zielgerichtete Therapie des HER2-positiven Mammakarzinoms. Thieme drug report.
Chicago Style (17th ed.) CitationSchneeweiss, Andreas. "Pertuzumab: Effektive Zielgerichtete Therapie Des HER2-positiven Mammakarzinoms." Thieme Drug Report 2015.
MLA (9th ed.) CitationSchneeweiss, Andreas. "Pertuzumab: Effektive Zielgerichtete Therapie Des HER2-positiven Mammakarzinoms." Thieme Drug Report, 2015.
Warning: These citations may not always be 100% accurate.